Ciclosporin: prescribe by brand

Ciclosporin should be prescribed and dispensed by brand, according to new advice issued by the MHRA.

As a critical-dose drug, ciclosporin has a narrow therapeutic window; consequently, even minor differences in bioavailability can affect blood levels, side effects and transplant function.

The MHRA's recommendations state that brands of ciclosporin (these include Neoral, Sandimmun and Deximune) should not be considered interchangeable unless careful therapeutic monitoring takes place.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more